Contingency Management for PrEP Adherence and/or Methamphetamine Use

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Methamphetamine-dependenceHIV-1-infection
Interventions
BEHAVIORAL

Contingency Management-ART

Participants in this arm will participate in a Contingency Management intervention where rewards are linked with demonstrated adherence to tenofovir-based ART or PrEP.

BEHAVIORAL

Contingency Management-Methamphetamine

Participants in this arm will participate in a Contingency Management intervention where rewards are linked with demonstrated abstinence from methamphetamine use.

Trial Locations (1)

90038

UCLA Vine Street Clinic, Los Angeles

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

University of California, Los Angeles

OTHER

NCT04563962 - Contingency Management for PrEP Adherence and/or Methamphetamine Use | Biotech Hunter | Biotech Hunter